These guidelines describe which biologic DMARDs are indicated for specific RA disease profiles (e.g., features such as disease activity, signs and symptoms, and prognosis)The 2008 guidelines also recommend that treatment with non-biologic and biologic therapies should be accompanied by non-medical interventions including physical and occupational therapy and anti-inflammatory pharmacologic interve